Firebrick Pharma LimitedASX: FRE

New Product - Nasodine Sinus Rinse

· Issued by Firebrick Pharma Limited via ASX

Filed with ASX · · 2 pages · English

Summary by 6ix AI

Firebrick Pharma Limited has announced the launch of its new product, Nasodine® Sinus Rinse, which is now available for healthcare professionals in Singapore. This product is an antiseptic nasal and sinus wash kit that utilizes povidone-iodine for its germ-killing properties. The announcement highlights the product's intended clinical uses and its role in the company's expanding portfolio of Nasodine products. The launch aims to provide comprehensive care for managing upper respiratory tract infections.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

21 October 2026 ASX Announcement ® New Product Launch: Nasodine Sinus Rinse Firebrick Pharma Limited (ASX: FRE) (the Company or Firebrick) is pleased to announce ® the launch of its third product in the Nasodine range: Nasodine Sinus Rinse. The product recently completed production and commercial...

Firebrick Pharma Limited on 6ix

Story so far

Earlier from Firebrick Pharma

Later from Firebrick Pharma

All Firebrick Pharma news releases